Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;25:453-459

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Madeddu, P.
Right arrow Articles by Glorioso, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Madeddu, P.
Right arrow Articles by Glorioso, N.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*SODIUM

(Hypertension. 1995;25:453-459.)
© 1995 American Heart Association, Inc.


Articles

Early Blockade of Bradykinin B2-Receptors Alters the Adult Cardiovascular Phenotype in Rats

Paolo Madeddu; Paolo Pinna Parpaglia; Maria Piera Demontis; Maria Vittoria Varoni; Maria Caterina Fattaccio; Vittorio Anania; Nicola Glorioso

From the Clinica Medica and Farmacologia, Sassari (Italy) University.

Abstract We evaluated whether long-term inhibition of bradykinin B2-receptors by the long-acting antagonist Hoe 140 (D-Arg,[Hyp3,Thi5,D-Tic7,Oic8]-bradykinin) affects the blood pressure of normotensive rats. Neither Hoe 140 (at 75 nmol/d for 8 weeks) nor its vehicle altered systolic pressure of adult rats on a normal or high sodium intake. In further experiments, pairs of Hoe 140–treated rats were mated and their offspring maintained on Hoe 140 and a normal sodium diet. Controls were given vehicle instead of Hoe 140. At 9 weeks of age, rats given Hoe 140 during prenatal and postnatal phases of life showed greater systolic pressures, heart rates, and body weights than controls (122±1 versus 113±1 mm Hg, 444±6 versus 395±8 beats per minute, 258±7 versus 213±3 g, respectively, P<.01), whereas urinary creatinine excretion was reduced (1.13±0.05 versus 1.36±0.04 µmol/100 g body wt in controls, P<.05). The difference in blood pressure (confirmed by direct intra-arterial measurement) persisted after 20 days of dietary sodium loading, whereas it was nullified by sodium restriction. In additional experiments, the offspring of untreated rats received Hoe 140 or vehicle from 2 days to 11 weeks of age. At this stage, systolic pressure and body weight were significantly greater in Hoe 140–treated rats compared with controls, and heart rate was similar. In addition, Hoe 140–treated rats showed higher sodium levels in serum and erythrocytes and a greater ratio of heart weight to body weight compared with controls; hematocrit and the ratio of kidney weight to body weight were lower. In conclusion, long-term blockade of bradykinin receptors by Hoe 140 alters the adult cardiovascular phenotype, provided that the antagonist is given since the early phases of life. Our data suggest that endogenous kinins may play a role in the regulation of cardiovascular function by influencing renal function and the activity of the sympathetic nervous system during development.


Key Words: bradykinin • kallikrein-kinin system • kidney • blood pressure • phenotype




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Duka, I. Duka, G. Gao, S. Shenouda, I. Gavras, and H. Gavras
Role of bradykinin B1 and B2 receptors in normal blood pressure regulation
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E268 - E274.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Duka, E. Kintsurashvili, I. Gavras, C. Johns, M. Bresnahan, and H. Gavras
Vasoactive Potential of the B1 Bradykinin Receptor in Normotension and Hypertension
Circ. Res., February 16, 2001; 88(3): 275 - 281.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Emanueli, R. Maestri, D. Corradi, R. Marchione, A. Minasi, M. G. Tozzi, M. B. Salis, S. Straino, M. C. Capogrossi, G. Olivetti, et al.
Dilated and Failing Cardiomyopathy in Bradykinin B2 Receptor Knockout Mice
Circulation, December 7, 1999; 100(23): 2359 - 2365.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. Zicha and J. Kunes
Ontogenetic Aspects of Hypertension Development: Analysis in the Rat
Physiol Rev, October 1, 1999; 79(4): 1227 - 1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. S. El-Dahr, S. Dipp, I. V. Yosipiv, and L. A. Carbini
Activation of kininogen expression during distal nephron differentiation
Am J Physiol Renal Physiol, July 1, 1998; 275(1): F173 - F182.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Emanueli, E. Fink, A. F. Milia, M. B. Salis, M. Conti, M. P. Demontis, and P. Madeddu
Enhanced Blood Pressure Sensitivity to Deoxycorticosterone in Mice With Disruption of Bradykinin B2 Receptor Gene
Hypertension, June 1, 1998; 31(6): 1278 - 1283.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Partovian, A. Benetos, J.-P. Pommies, W. Mischler, and M. E. Safar
Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin
Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1423 - H1428.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Madeddu, M. V. Varoni, D. Palomba, C. Emanueli, M. P. Demontis, N. Glorioso, P. Dessi-Fulgheri, R. Sarzani, and V. Anania
Cardiovascular Phenotype of a Mouse Strain With Disruption of Bradykinin B2-Receptor Gene
Circulation, November 18, 1997; 96(10): 3570 - 3578.
[Abstract] [Full Text]


Home page
BloodHome page
R. W. Colman and A. H. Schmaier
Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes
Blood, November 15, 1997; 90(10): 3819 - 3843.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Benetos, B. I. Levy, P. Lacolley, F. Taillard, M. Duriez, and M. E. Safar
Role of Angiotensin II and Bradykinin on Aortic Collagen Following Converting Enzyme Inhibition in Spontaneously Hypertensive Rats
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3196 - 3201.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. Madeddu, M. V. Varoni, M. P. Demontis, J. Chao, J. A. Simson, N. Glorioso, and V. Anania
Kallikrein-Kinin System and Blood Pressure Sensitivity to Salt
Hypertension, January 1, 1997; 29(1): 471 - 477.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. McCarty and J. H. Lee
Preweanling Administration of Terazosin Decreases Blood Pressure of Hypertensive Rats in Adulthood
Hypertension, May 1, 1996; 27(5): 1115 - 1120.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. Madeddu, P. P. Parpaglia, V. Anania, N. Glorioso, C. Chao, C. Wang, and J. Chao
Sexual Dimorphism of Cardiovascular Responses to Early Blockade of Bradykinin Receptors
Hypertension, March 1, 1996; 27(3): 746 - 751.
[Abstract] [Full Text]


Home page
HypertensionHome page
B. Jover, A. Herizi, and A. Mimran
Chronic Kinin Blockade and Effect of Ramipril in Renal Adaptation to Sodium Restriction
Hypertension, January 1, 1996; 27(1): 79 - 84.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. S. Margolius
Kallikreins and Kinins : Some Unanswered Questions About System Characteristics and Roles in Human Disease
Hypertension, August 1, 1995; 26(2): 221 - 229.
[Abstract] [Full Text]


Home page
HypertensionHome page
P. Madeddu, P. P. Parpaglia, M. P. Demontis, M. V. Varoni, M. C. Fattaccio, V. Anania, and N. Glorioso
Effects of Kinin Blockade on the Blood Pressure of Salt-Loaded Pregnant Rats
Hypertension, April 1, 1995; 25(4): 823 - 827.
[Abstract] [Full Text]